Determination of free growth hormone

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 8, 2008, Pages 3008-3014

  Frystyk, Jan ^a   Andreasen, Caroline Marie ^a   Fisker, Sanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; GROWTH HORMONE BINDING PROTEIN ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN TOLERANCE TEST; MALE; PRIORITY JOURNAL; SERUM; ULTRAFILTRATION;

EID: 49249100002     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0375     Document Type: Article

References (33)

1. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
2. Baumann G 1991 Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr Rev 12:424-449
3. Baumann G 1999 Growth hormone heterogeneity in human pituitary and plasma. Horm Res 51(Suppl 1):2-6
4. Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC 1986 A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62:134-141
5. Fuh G, Mulkerrin MG, Bass S, McFarland N, Brochier M, Bourell JH, Light DR, Wells JA 1990 The human growth hormone receptor. Secretion from Escherichia coli and disulfide bonding pattern of the extracellular binding domain. J Biol Chem 265:3111-3115
6. Fisker S 2006 Physiology and pathophysiology of growth hormone-binding protein: methodological and clinical aspects. Growth Horm IGF Res 16:1-28
7. Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G 1993 Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications. J Clin Invest 91:629-641
8. Baumann G, Amburn K, Shaw MA 1988 The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. Endocrinology 122:976-984
9. Baumann G, Lowman HB, Mercado M, Wells JA 1994 The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors. J Clin Endocrinol Metab 78:1113-1118
10. Ross RJ, Leung KC, Maamra M, Bennett W, Doyle N, Waters MJ, Ho KK 2001 Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinol Metab 86:1716-1723
11. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858-9863
12. Tar A, Hocquette JF, Souberbielle JC, Clot JP, Brauner R, Postel-Vinay MC 1990 Evaluation of the growth hormone-binding proteins in human plasma using high pressure liquid chromatography gel filtration. J Clin Endocrinol Metab 71:1202-1207
13. Baumann G, Shaw MA 1990 A second, lower affinity growth hormone-binding protein in human plasma. J Clin Endocrinol Metab 70:680-686
14. Kratzsch J, Selisko T, Birkenmeier G 1995 Identification of transformed α2-macroglobulin as a growth hormone-binding protein in human blood. J Clin Endocrinol Metab 80:585-590
15. Mannor DA, Winer LM, Shaw MA, Baumann G 1991 Plasma growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action. J Clin Endocrinol Metab 73:30-34
16. Lim L, Spencer SA, McKay P, Waters MJ 1990 Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 127:1287-1291
17. Tzanela M, Wagner C, Tannenbaum GS 1997 Recombinant human growth hormone-binding protein fails to enhance the in vivo bioactivity of human growth hormone in normal rats. Endocrinology 138:5316-5324
18. Turyn D, Dominici FP, Sotelo AI, Bartke A 1997 Growth hormone-binding protein enhances growth hormone activity in vivo. Am J Physiol 273:E549-E556
19. Clark RG, Mortensen DL, Carlsson LM, Spencer SA, McKay P, Mulkerrin M, Moore J, Cunningham BC 1996 Recombinant human growth hormone (GH)-binding protein enhances the growth-promoting activity of human GH in the rat. Endocrinology 137:4308-4315
20. Fairhall KM, Carmignac DF, Robinson IC 1992 Growth hormone (GH) binding protein and GH interactions in vivo in the guinea pig. Endocrinology 131:1963-1969
21. Baumann G, Amburn KD, Buchanan TA 1987 The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. J Clin Endocrinol Metab 64:657-660
22. Hansen TK, Fisker S, Hansen B, Sørensen HH, Christiansen JS, Jørgensen JO, Ørskov H 2002 Impact of GHBP interference on estimates of GH and GH pharmacokinetics. Clin Endocrinol (Oxf) 57:779-786
23. Veldhuis JD, Bidlingmaier M, Anderson SM, Evans WS, Wu Z, Strasburger CJ 2002 Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men. J Clin Endocrinol Metab 87:5737-5745
24. Frystyk J, Skjærbæk C, Dinesen B, Ørskov H 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348:185-191
25. Ekins R 1990 Measurement of free hormone in blood. Endocr Rev 11:5-46
26. Wan Y, Zheng YZ, Harris JM, Brown R, Waters MJ 2003 Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263. Mol Endocrinol 17:2240-2250
27. Fisker S, Frystyk J, Skriver L, Vestbo E, Ho KK, Ørskov H 1996 A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum. Eur J Clin Invest 26:779-785
28. Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A 1993 Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 39:1620-1625
29. Frystyk J, Skjærbæk C, Vestbo E, Fisker S, Ørskov H 1999 Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314-322
30. Ebdrup L, Fisker S, Sørensen HH, Ranke MB, Ørskov H 1999 Variety in growth hormone determinations due to use of different immunoassays and to the interference of growth hormone-binding protein. Horm Res 51(Suppl 1):20-26
31. Barsano CP, Baumann G 1989 Simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone? Endocrinology 124:1101-1106
32. Rowland JE, Marshall NJ, Leung Kc, Ho KKY, Cotterill AM, Rowlinson SW, Waters MJ 2002 A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays. Clin Endocrinol (Oxf) 56:475-485
33. Greenwood FC, Landon J, Stamp TC 1966 The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest 45:429-436